Newbridge Financial Services Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,500
| Closed | -$25.4K | – | 1416 |
|
|
2022
Q4 | $25.4K | Sell |
1,500
-1,000
| -40% | -$17K | 0.01% | 646 |
|
|
2022
Q3 | $37K | Sell |
2,500
-64
| -2% | -$947 | 0.02% | 524 |
|
|
2022
Q2 | $40K | Sell |
2,564
-500
| -16% | -$7.8K | 0.02% | 454 |
|
|
2022
Q1 | $83K | Sell |
3,064
-850
| -22% | -$23K | 0.04% | 350 |
|
|
2021
Q4 | $145K | Sell |
3,914
-200
| -5% | -$7.41K | 0.07% | 242 |
|
|
2021
Q3 | $197K | Buy |
4,114
+3,850
| +1,458% | +$184K | 0.12% | 174 |
|
|
2021
Q2 | $9K | Hold |
264
| – | – | 0.01% | 1001 |
|
|
2021
Q1 | $11K | Sell |
264
-329
| -55% | -$13.7K | 0.01% | 860 |
|
|
2020
Q4 | $26K | Buy |
593
+500
| +538% | +$21.9K | 0.02% | 472 |
|
|
2020
Q3 | $4K | Buy |
+93
| New | +$4K | ﹤0.01% | 831 |
|